GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » Price-to-Funds-From-Operations

Atreca (FRA:0C1) Price-to-Funds-From-Operations : (As of Sep. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Atreca Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Atreca Business Description

Industry
Traded in Other Exchanges
Address
835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.